Squarepoint’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $829K | Buy |
17,571
+629
| +4% | +$29.7K | ﹤0.01% | 1629 |
|
|
2025
Q1 | $662K | Buy |
+16,942
| New | +$662K | ﹤0.01% | 1739 |
|
|
2024
Q4 | – | Sell |
-6,402
| Closed | -$323K | – | 3064 |
|
|
2024
Q3 | $323K | Sell |
6,402
-938
| -13% | -$47.3K | ﹤0.01% | 1960 |
|
|
2024
Q2 | $323K | Buy |
+7,340
| New | +$323K | ﹤0.01% | 1933 |
|
|
2024
Q1 | – | Sell |
-18,903
| Closed | -$1.14M | – | 2736 |
|
|
2023
Q4 | $1.14M | Buy |
18,903
+4,994
| +36% | +$302K | ﹤0.01% | 1293 |
|
|
2023
Q3 | $793K | Sell |
13,909
-27,522
| -66% | -$1.57M | ﹤0.01% | 1419 |
|
|
2023
Q2 | $2.11M | Buy |
+41,431
| New | +$2.11M | 0.01% | 878 |
|